Author:
Li Ye,Zhu Jianjun,Zhao Nan,Ma Gang,Liu Bohu,Xu Jiajun
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Y.F. Mustafa, N.A. Mohammed, A promising oral 5-Fluorouracil prodrug for lung tumor: Synthesis, characterization, and release. Biochem. Cell. Arch. 21, (2021)
2. P.H. Sugarbaker, After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye. Surg. Oncol. 42, 101757 (2022)
3. Y. Qin, J. Xie, H. Wang, Efficacy and safety of combined use of docetaxelgemcitabine chemotherapy and 5-fluorouracil targeted therapy in the treatment of advanced non-small cell lung cancer. Trop. J. Pharm. Res. 21(7), 1523–1529 (2022)
4. A.A. Valencia-Lazcano, D. Hassan, M. Pourmadadi, R. Behzadmehr, A. Rahdar, D.I. Medina, A.M. Díez-Pascual, 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy. Eur. J. Med. Chem. 246, 114995 (2023)
5. T.T. Dongsar, T.S. Dongsar, N. Gupta, W.H. Almalki, A. Sahebkar, P. Kesharwani, Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy. J. Drug Deliv. Sci. Technol. 104371 (2023)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献